Nancy Nongying Wu MD, Ms
About Nancy Nongying Wu MD, Ms
Nancy Nongying Wu, MD, Ms, is the Associate Medical Director of Global Patient Safety at BeiGene, with extensive experience in translational medicine research and global pharmacovigilance.
Current Role at BeiGene
Nancy Nongying Wu is currently serving as the Associate Medical Director in Global Patient Safety at BeiGene, located in Ridgefield Park, New Jersey. In this role, she is responsible for overseeing patient safety protocols and ensuring compliance with global safety standards. Her responsibilities likely include clinical trial safety monitoring, safety data review, and risk evaluations, as well as contributing to the development of drug safety policies and procedures.
Previous Experience at Beacon Hill Pharma
Prior to joining BeiGene, Nancy worked at Beacon Hill Pharma as a Clinical Safety Physician Consultant. During her six-month tenure from 2019 to 2020 in the Greater New York City Area, she provided consultancy services focused on clinical safety, contributing her expertise in clinical trial safety data monitoring and regulatory safety assessments.
Career at Sanofi
Nancy Nongying Wu spent a significant part of her career at Sanofi, taking on various roles over a span of 11 years in Bridgewater, New Jersey. She started as a Senior Scientist from 2006 to 2012, moved on to become a Senior Coding Specialist in Medical Operation Development from 2012 to 2017, and later worked as a Case Medical Safety Expert in GPV Global PV Operations from 2017 to 2019. These roles involved extensive work in clinical trial safety data coding (MedDRA and WHODD), aggregate safety data review, case processing, and regulatory assessments.
Educational Background
Nancy holds a Doctor of Medicine (MD) and a Master's degree in Pathophysiology from West China Medical University of Sichuan University. Additionally, she earned an MA in Biochemistry from the University of Scranton. Her robust educational background provided her with a strong foundation in medical sciences, which she has applied throughout her extensive career in clinical research and safety.
Expertise in Clinical Trials and Safety
Nancy has a proven track record in the fields of global pharmacovigilance and clinical trials, with a primary focus on drug discovery and clinical research. She is proficient in MedDRA and WHODD coding, ensuring accuracy and compliance in clinical trial data. Her expertise includes individual case medical and regulatory assessments, clinical trial protocol development, signal detection, and safety management plans. Additionally, Nancy is adept at conducting safety data reviews and contributing to the overall efficacy and safety of clinical trials, particularly in therapeutic areas such as immune and inflammatory disorders, diabetes, cardiovascular, oncology, and neurology.